News

Adding significant financial expertise with an impressive track record in value creation

The Company’s Pharma and CRO business development team and Diagnostics sales team will be attending events in the U.S. and Spain. CENTOGENE invites…

Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the…

Company management and the business development team will be attending events in the U.K. and Germany. CENTOGENE invites partners to schedule…

Working together with Denali Therapeutics to accelerate data-driven precision medicine for the PD community

Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced…

Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced…

Interim CFO Miguel Coego Rios appointed as Managing Director and permanent CFO. Centogene N.V. today announced the appointment of Miguel Coego Rios as…

Centogene N.V. today announced the voting results of the Company’s Annual General Meeting. Shareholders voted in favor of all proposals, which…

Working together on the world’s first treatment that targets the underlying causes of pyruvate kinase (“PK”) deficiency in children under the age of…